Dual specificity phosphatase 6 as a new therapeutic target candidate for epithelial ovarian cancer

被引:1
|
作者
Sato, Seiya [1 ]
Itamochi, Hiroaki [2 ]
机构
[1] Shimane Univ, Sch Med, Dept Obstet & Gynecol, Izumo, Shimane, Japan
[2] Iwate Med Univ, Sch Med, Dept Clin Oncol, Yahaba, Iwate, Japan
关键词
ONCOGENE ADDICTION; BEVACIZUMAB; INHIBITION; DUSP6;
D O I
10.21037/atm.2019.12.105
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:5
相关论文
共 50 条
  • [31] RNA Interference Against Cancer/Testis Genes Identifies Dual Specificity Phosphatase 21 as a Potential Therapeutic Target in Human Hepatocellular Carcinoma
    Deng, Qing
    Li, Kun-Yu
    Chen, Hui
    Dai, Ji-Hong
    Zhai, Yang-Yang
    Wang, Qun
    Li, Niu
    Wang, Yu-Ping
    Han, Ze-Guang
    [J]. HEPATOLOGY, 2014, 59 (02) : 518 - 530
  • [32] MONOAMINE OXIDASE A: A NEW CANDIDATE THERAPEUTIC TARGET FOR ADVANCED PROSTATE CANCER
    Flamand, V.
    Zhao, H.
    Peehl, D. M.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 274 - 274
  • [33] Identification of a new candidate therapeutic target for gastric cancer by in silico analysis
    Kohmoto, Tomohiro
    Masuda, Kiyoshi
    Shoda, Katsutoshi
    Fujita, Yuji
    Tange, Shoichiro
    Ichikawa, Daisuke
    Otsuji, Eigo
    Imoto, Issei
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [34] Glucose-6-phosphate dehydrogenase: a therapeutic target for ovarian cancer
    Wang, Chenxi
    Yu, Chenxi
    Chang, Hongkai
    Song, Jiaqi
    Zhang, Shuai
    Zhao, Jianguo
    Wang, Jiyan
    Wang, Tao
    Qi, Qi
    Shan, Changliang
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2023, 27 (08) : 733 - 743
  • [35] Therapeutic strategies in epithelial ovarian cancer
    Ayako Kim
    Yutaka Ueda
    Tetsuji Naka
    Takayuki Enomoto
    [J]. Journal of Experimental & Clinical Cancer Research, 31
  • [36] Therapeutic strategies in epithelial ovarian cancer
    Kim, Ayako
    Ueda, Yutaka
    Naka, Tetsuji
    Enomoto, Takayuki
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2012, 31
  • [37] PTP4A3 phosphatase is a novel drug target for epithelial ovarian cancer.
    Cornelison, John Robert
    Rastelli, Ettore J.
    Hart, Duncan J.
    Mendelson, Anna J.
    Sharlow, Elizabeth R.
    Wipf, Peter
    Lazo, John S.
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [38] TrkB as a therapeutic target for ovarian cancer
    Siu, Michelle K. Y.
    Wong, Oscar G. W.
    Cheung, Annie N. Y.
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (10) : 1169 - 1178
  • [39] Quiescence as a therapeutic target in ovarian cancer
    Ertel, Michelle
    Brunhilda, Tonge
    Panesso, Santiago
    Sannino, Sara
    Sagan, April
    McGonigal, Stacy
    Jiang, Qi
    Brodsky, Jeffrey
    Osmanbeyoglu, Hatice
    Buckanovich, Ronald
    [J]. GYNECOLOGIC ONCOLOGY, 2023, 176 : S155 - S156
  • [40] EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer
    Bradley, Amber
    Zheng, Hui
    Ziebarth, Angela
    Sakati, Wayne
    Branham-O'Connor, Melissa
    Blumer, Joe B.
    Liu, Yuying
    Kistner-Griffin, Emily
    Rodriguez-Aguayo, Cristian
    Lopez-Berestein, Gabriel
    Sood, Anil K.
    Landen, Charles N., Jr.
    Eblen, Scott T.
    [J]. CARCINOGENESIS, 2014, 35 (05) : 1100 - 1109